Form 4 · Filed Jul 6, 2026, 10:09 PM UTC
TAK/TAKEDA PHARMACEUTICAL CO LTD
Furuta Milano — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | D | other | 16,619 | — | — | 0 |
| Jul 1, 2026 | A | other | 12,300 | $0 | — | 70,200 |
| Jul 1, 2026 | A | other | 4,288 | — | — | 11,741 |
| Jul 1, 2026 | A | other | 4,288 | — | — | 8,482 |
| Jul 1, 2026 | A | other | 4,288 | — | — | 4,288 |
Source: SEC EDGAR raw filing ↗ · Accession 0001395064-26-000260